Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.
Early research on radio-frequency ablation (RFA) in the breast shows promising results, prompting hope that the procedure may one day offer an alternative to surgical resection for small tumors.
Using RFA to treat tumors in 26 patients with biopsy-proven T1 and T2 breast carcinoma, researchers in Italy and at the University of Texas M.D. Anderson Cancer Center aimed for complete ablation and a 5-mm margin. They achieved complete tumor necrosis in 25 of 26 patients, or 96%.
Traditional surgery, such as lumpectomy, usually takes about an hour. Researchers reported a mean treatment time for two-phase RFA of 15 minutes and 23 seconds.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.